Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


30.03.2020

6 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 Am J Surg
1 BMC Gastroenterol
1 Clin Gastroenterol Hepatol
4 Dig Dis Sci
2 Dis Colon Rectum
4 Gastroenterology
12 Inflamm Bowel Dis
1 J Clin Gastroenterol
4 J Crohns Colitis
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. ADAR T, Faleck D, Sasidharan S, Cushing K, et al
    Comparative safety and effectiveness of tumor necrosis factor alpha antagonists and vedolizumab in elderly IBD patients: a multicentre study.
    Aliment Pharmacol Ther. 2019;49:873-879.
    PubMed         Abstract available

  2. HUPE M, Riviere P, Nancey S, Roblin X, et al
    Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study.
    Aliment Pharmacol Ther. 2020 Mar 22. doi: 10.1111/apt.15680.
    PubMed         Abstract available

  3. LIN YS, Cheng SW, Wang YH, Chen KH, et al
    Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn's disease.
    Aliment Pharmacol Ther. 2019;49:966-977.
    PubMed         Abstract available

  4. CASTIGLIONE F, Imperatore N, Testa A, De Palma GD, et al
    One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing.
    Aliment Pharmacol Ther. 2019;49:1026-1039.
    PubMed         Abstract available

  5. CATT H, Hughes D, Kirkham JJ, Bodger K, et al
    Systematic review: outcomes and adverse events from randomised trials in Crohn's disease.
    Aliment Pharmacol Ther. 2019;49:978-996.
    PubMed         Abstract available

  6. SHAH SC, Khalili H, Chen CY, Ahn HS, et al
    Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region.
    Aliment Pharmacol Ther. 2019;49:904-911.
    PubMed         Abstract available


    Am J Gastroenterol

  7. WALLENHORST T, Jacques J, Bouguen G, Pagenault M, et al
    Successful Closure of a Rectal Fistula of Crohn's Disease Using Endoscopic Submucosal Dissection Combined With an Over-the-Scope Clip.
    Am J Gastroenterol. 2019;114:1416.
    PubMed        


    Am J Surg

  8. ONWUKA E, Huntington J, Onwuka A, Prasad V, et al
    Acute histologic inflammatory activity and postoperative outcomes in pediatric patients with ulcerative colitis.
    Am J Surg. 2020 Mar 11. pii: S0002-9610(20)30135.
    PubMed         Abstract available


    BMC Gastroenterol

  9. PAPA V, Giustiniani MC, Lopetuso LR, Papa A, et al
    Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature.
    BMC Gastroenterol. 2020;20:76.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  10. LAI SW, Kuo YH, Liao KF
    Association Between Inflammatory Bowel Disease and Diabetes Mellitus.
    Clin Gastroenterol Hepatol. 2020;18:1002-1003.
    PubMed        


    Dig Dis Sci

  11. PAREDES JM, Moreno N, Latorre P, Ripolles T, et al
    Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:2600-2606.
    PubMed         Abstract available

  12. CONLEY S, Jeon S, Lehner V, Proctor DD, et al
    Sleep Characteristics and Rest-Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 19. pii: 10.1007/s10620-020-06213.
    PubMed         Abstract available

  13. FRIAS GOMES C, Narula N, Morao B, Nicola P, et al
    Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 21. pii: 10.1007/s10620-020-06204.
    PubMed         Abstract available

  14. GUPTA A, Wash C, Wu Y, Sorrentino D, et al
    Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 23. pii: 10.1007/s10620-020-06205.
    PubMed         Abstract available


    Dis Colon Rectum

  15. LEE GC, Cavallaro PM, Savitt LR, Hodin RA, et al
    Bowel Function After J-Pouch May Be More Complex Than Previously Appreciated: A Comprehensive Analysis to Highlight Existing Knowledge Gaps.
    Dis Colon Rectum. 2020;63:207-216.
    PubMed         Abstract available

  16. BOLCKMANS R, Kalman T, Singh S, Ratnatunga KC, et al
    Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?
    Dis Colon Rectum. 2020;63:200-206.
    PubMed         Abstract available


    Gastroenterology

  17. FRITSCH J, Abreu MT
    Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.
    Gastroenterology. 2020;158:470-472.
    PubMed        

  18. AGRAWAL M, Ungaro RC, Colombel JF
    New Blood Marker of Endoscopic Disease Activity-A Step Forward in Treating Crohn's Disease to Target?
    Gastroenterology. 2020;158:463-465.
    PubMed        

  19. SPENCER EA, Helmus D, Telesco S, Colombel JF, et al
    Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30365.
    PubMed        

  20. BAMIAS G, Rivera-Nieves J, Mantzaris GJ
    Efficacy of IL12/23 blockade expands our therapeutic targets and challenges the old dogma in ulcerative colitis.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30366.
    PubMed         Abstract available


    Inflamm Bowel Dis

  21. PLEVRIS N, Lyons M, Jenkinson PW, Chuah CS, et al
    Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.
    Inflamm Bowel Dis. 2019;25:1036-1043.
    PubMed         Abstract available

  22. PARK SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al
    Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.
    Inflamm Bowel Dis. 2019;25:1054-1060.
    PubMed         Abstract available

  23. SCHMIDT T, Feagins LA
    How Can We Improve to Keep Our Patients Out of the Hospital?
    Inflamm Bowel Dis. 2019;25:980-986.
    PubMed         Abstract available

  24. SADO AI, Kalla R, Sharma A
    A Case of IBD Immunosuppression Related Salmonella Aortitis Requiring Emergency Vascular Grafting.
    Inflamm Bowel Dis. 2019;25:e64.
    PubMed        

  25. QAZI T, Verma R, Hamilton MJ, Kaplan ER, et al
    The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1044-1053.
    PubMed         Abstract available

  26. KOTZEV A, Tanchev L, Encheva L, Kovachev N, et al
    Sigmoidouterine Fistula in Crohn's Disease: A First Case Report.
    Inflamm Bowel Dis. 2019;25:e65-e66.
    PubMed        

  27. MOORE AC, Huang VW, Bourdages R, Fedorak RN, et al
    IBDoc Canadian User Performance Evaluation.
    Inflamm Bowel Dis. 2019;25:1107-1114.
    PubMed         Abstract available

  28. CALDERA F, Hayney MS, Cross RK
    Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.
    Inflamm Bowel Dis. 2019;25:955-957.
    PubMed        

  29. COUCH DG, Cook H, Ortori C, Barrett D, et al
    Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Inflamm Bowel Dis. 2019;25:1006-1018.
    PubMed         Abstract available

  30. XIE H, Zeng D, Chen D, Tang W, et al
    Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Mar 20. pii: 5810369. doi: 10.1093.
    PubMed        

  31. MCCURDY JD, Benchimol EI
    Response to Letter, "Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Mar 21. pii: 5810826. doi: 10.1093.
    PubMed        

  32. ORFANOUDAKI E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE, et al
    Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 24. pii: 5811190. doi: 10.1093.
    PubMed        


    J Clin Gastroenterol

  33. HASHASH JG, Vachon A, Ramos Rivers C, Regueiro MD, et al
    Predictors of Suicidal Ideation Among IBD Outpatients.
    J Clin Gastroenterol. 2019;53:e41-e45.
    PubMed         Abstract available


    J Crohns Colitis

  34. IACUCCI M, Cannatelli R, Gui XS, Zardo D, et al
    Assessment of endoscopic healing by using advanced technologies reflects histologic healing in ulcerative colitis.
    J Crohns Colitis. 2020 Mar 23. pii: 5810912. doi: 10.1093.
    PubMed         Abstract available

  35. CALAFAT M, Manosa M, Mesonero F, Guardiola J, et al
    Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry.
    J Crohns Colitis. 2020 Mar 23. pii: 5810964. doi: 10.1093.
    PubMed         Abstract available

  36. VAN ANDEL EM, Koopmann BDM, Crouwel F, Noomen CG, et al
    Systematic review of development and content validity of patient-reported outcome measures in Inflammatory Bowel Disease: do we measure what we measure?
    J Crohns Colitis. 2020 Mar 25. pii: 5811405. doi: 10.1093.
    PubMed         Abstract available

  37. FIORINO G, Allocca M, Furfaro F, Gilardi D, et al
    Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.
    J Crohns Colitis. 2020 Mar 24. pii: 5811431. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  38. KUBOTA M, Kakimoto K, Nakagawa T, Koubayashi E, et al
    Autophagy deficiency exacerbates colitis through excessive oxidative stress and MAPK signaling pathway activation.
    PLoS One. 2019;14:e0225066.
    PubMed         Abstract available

  39. ABBAS M, Matta J, Le T, Bensmail H, et al
    Biomarker discovery in inflammatory bowel diseases using network-based feature selection.
    PLoS One. 2019;14:e0225382.
    PubMed         Abstract available

  40. WOLOSZYNEK S, Mell JC, Zhao Z, Simpson G, et al
    Exploring thematic structure and predicted functionality of 16S rRNA amplicon data.
    PLoS One. 2019;14:e0219235.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  41. HENKE MT, Kenny DJ, Cassilly CD, Vlamakis H, et al
    Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide.
    Proc Natl Acad Sci U S A. 2019;116:12672-12677.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: